Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.5B | 9.3B | 9.2B | 9.1B |
Cost of revenue | 6.9B | 7.3B | 7.2B | 7.3B |
Gross profit | 1.6B | 2.0B | 1.9B | 1.9B |
Operating expense | ||||
Research & development | 172M | 192M | 187M | 188M |
Selling general and admin | 96M | 80M | 90M | 94M |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.7B | 1.6B | 1.6B |
Non operating interest income | ||||
Income | 36M | 45M | 52M | 38M |
Expense | 147M | 131M | 136M | 132M |
Other income expense | -164M | -216M | -54M | -80M |
Pretax income | 1.1B | 1.4B | 1.5B | 1.4B |
Tax provision | 234M | 269M | 289M | 276M |
Net income | 829M | 1.1B | 1.2B | 1.1B |
Basic EPS | 0.6 | 0.8 | 0.8 | 0.8 |
Diluted EPS | 0.6 | 0.8 | 0.8 | 0.8 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 2.1B | 1.8B | 2.4B | 2.3B |
Net income from continuing op. | 829M | 1.1B | 1.2B | 1.1B |
Minority interests | -32M | -23M | -32M | -33M |
Preferred stock dividends | — | — | — | — |